Cargando…
Polytherapy and drug interactions in elderly
There is an increase in population of elderly above the age of 65. As age advances, more diseases develop resulting in use of more medications. Physiological changes, alterations in homeostatic regulation and diseases modify pharmacokinetics and drug response in older patients. The risk for drug int...
Autor principal: | Gujjarlamudi, Hima Bindu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051228/ https://www.ncbi.nlm.nih.gov/pubmed/27721636 http://dx.doi.org/10.4103/0976-7800.191021 |
Ejemplares similares
-
Rational Polytherapy with Antiepileptic Drugs
por: Lee, Jong Woo, et al.
Publicado: (2010) -
Scoping review of rational polytherapy in patients with drug‐resistant epilepsy
por: Grinalds, McKenzie S., et al.
Publicado: (2022) -
Truly “Rational” Polytherapy: Maximizing Efficacy and Minimizing Drug Interactions, Drug Load, and Adverse Effects
por: St. Louis, Erik K
Publicado: (2009) -
In vitro safety “clinical trial” of the cardiac liability of drug polytherapy
por: Charrez, Bérénice, et al.
Publicado: (2021) -
Monotherapy to Polytherapy: Antiepileptic Drug Conversions Through the Spectrum of Epilepsy Care
por: St. Louis, Erik K
Publicado: (2009)